Last reviewed · How we verify

Infusion of Ropivacaine during 48 hours

University Hospital, Rouen · Phase 3 active Small molecule

Infusion of Ropivacaine during 48 hours is a Local anesthetic (amide class) Small molecule drug developed by University Hospital, Rouen. It is currently in Phase 3 development for Postoperative pain management via continuous peripheral nerve block or infiltration, Regional anesthesia for surgical procedures.

Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials. Used for Postoperative pain management via continuous peripheral nerve block or infiltration, Regional anesthesia for surgical procedures.

At a glance

Generic nameInfusion of Ropivacaine during 48 hours
SponsorUniversity Hospital, Rouen
Drug classLocal anesthetic (amide class)
TargetVoltage-gated sodium channels
ModalitySmall molecule
Therapeutic areaAnesthesia/Pain Management
PhasePhase 3

Mechanism of action

Ropivacaine reversibly inhibits sodium influx into nerve fibers, which stabilizes the neuronal membrane and prevents depolarization. This action blocks pain signal transmission along peripheral nerves. When infused continuously over 48 hours, it provides prolonged regional anesthesia or analgesia to a localized area.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Infusion of Ropivacaine during 48 hours

What is Infusion of Ropivacaine during 48 hours?

Infusion of Ropivacaine during 48 hours is a Local anesthetic (amide class) drug developed by University Hospital, Rouen, indicated for Postoperative pain management via continuous peripheral nerve block or infiltration, Regional anesthesia for surgical procedures.

How does Infusion of Ropivacaine during 48 hours work?

Ropivacaine is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and propagation of action potentials.

What is Infusion of Ropivacaine during 48 hours used for?

Infusion of Ropivacaine during 48 hours is indicated for Postoperative pain management via continuous peripheral nerve block or infiltration, Regional anesthesia for surgical procedures.

Who makes Infusion of Ropivacaine during 48 hours?

Infusion of Ropivacaine during 48 hours is developed by University Hospital, Rouen (see full University Hospital, Rouen pipeline at /company/university-hospital-rouen).

What drug class is Infusion of Ropivacaine during 48 hours in?

Infusion of Ropivacaine during 48 hours belongs to the Local anesthetic (amide class) class. See all Local anesthetic (amide class) drugs at /class/local-anesthetic-amide-class.

What development phase is Infusion of Ropivacaine during 48 hours in?

Infusion of Ropivacaine during 48 hours is in Phase 3.

What are the side effects of Infusion of Ropivacaine during 48 hours?

Common side effects of Infusion of Ropivacaine during 48 hours include Systemic toxicity (CNS effects: dizziness, tinnitus, seizures), Cardiovascular effects (hypotension, bradycardia), Local site reactions (erythema, edema), Nausea.

What does Infusion of Ropivacaine during 48 hours target?

Infusion of Ropivacaine during 48 hours targets Voltage-gated sodium channels and is a Local anesthetic (amide class).

Related